Cargando…
Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
SIMPLE SUMMARY: There is increasing evidence that obesity and high circulating cholesterol levels are associated with an increased risk of recurrence and a higher mortality rate in breast cancer patients via altering the metabolic programming in breast cancer cells. However, the underlying molecular...
Autores principales: | Ghanbari, Faegheh, Fortier, Anne-Marie, Park, Morag, Philip, Anie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198778/ https://www.ncbi.nlm.nih.gov/pubmed/34073320 http://dx.doi.org/10.3390/cancers13112605 |
Ejemplares similares
-
Cholesterol as an Endogenous Ligand of ERRα Promotes ERRα-Mediated Cellular Proliferation and Metabolic Target Gene Expression in Breast Cancer Cells
por: Ghanbari, Faegheh, et al.
Publicado: (2020) -
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer
por: Deblois, Geneviève, et al.
Publicado: (2016) -
Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway
por: Brindisi, Matteo, et al.
Publicado: (2020) -
Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment
por: Casaburi, Ivan, et al.
Publicado: (2018) -
IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells
por: He, Qing, et al.
Publicado: (2022)